These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 36758443)

  • 21. A step towards harmonising human biomonitoring study setup on European level: Materials provided and lessons learnt in HBM4EU.
    Pack LK; Gilles L; Cops J; Tolonen H; van Kamp I; Esteban-López M; Pedraza-Díaz S; Lacasaña M; Alzaga BG; Lermen D; Bartel-Steinbach M; Katsonouri A; Fiddicke U; Castaño A; Kolossa-Gehring M
    Int J Hyg Environ Health; 2023 Apr; 249():114118. PubMed ID: 36773579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PFASs: What can we learn from the European Human Biomonitoring Initiative HBM4EU.
    Uhl M; Schoeters G; Govarts E; Bil W; Fletcher T; Haug LS; Hoogenboom R; Gundacker C; Trier X; Fernandez MF; Calvo AC; López ME; Coertjens D; Santonen T; Murínová ĽP; Richterová D; Brouwere K; Hauzenberger I; Kolossa-Gehring M; Halldórsson ÞI
    Int J Hyg Environ Health; 2023 May; 250():114168. PubMed ID: 37068413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implementation of effect biomarkers in human biomonitoring studies: A systematic approach synergizing toxicological and epidemiological knowledge.
    Rodríguez-Carrillo A; Mustieles V; Salamanca-Fernández E; Olivas-Martínez A; Suárez B; Bajard L; Baken K; Blaha L; Bonefeld-Jørgensen EC; Couderq S; D'Cruz SC; Fini JB; Govarts E; Gundacker C; Hernández AF; Lacasaña M; Laguzzi F; Linderman B; Long M; Louro H; Neophytou C; Oberemn A; Remy S; Rosenmai AK; Saber AT; Schoeters G; Silva MJ; Smagulova F; Uhl M; Vinggaard AM; Vogel U; Wielsøe M; Olea N; Fernández MF
    Int J Hyg Environ Health; 2023 Apr; 249():114140. PubMed ID: 36841007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HBM4EU chromates study - Reflection and lessons learnt from designing and undertaking a collaborative European biomonitoring study on occupational exposure to hexavalent chromium.
    Galea KS; Porras SP; Viegas S; Bocca B; Bousoumah R; Duca RC; Godderis L; Iavicoli I; Janasik B; Jones K; Knudsen LE; Leese E; Leso V; Louro H; Ndaw S; Ruggieri F; Sepai O; Scheepers PTJ; Silva MJ; Wasowicz W; Santonen T
    Int J Hyg Environ Health; 2021 May; 234():113725. PubMed ID: 33714856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Learning from previous work and finding synergies in the domains of public and environmental health: EU-funded projects BRIDGE Health and HBM4EU.
    David M; Schwedler G; Reiber L; Tolonen H; Andersson AM; Esteban López M; Joas A; Schöpel M; Polcher A; Kolossa-Gehring M
    Arch Public Health; 2020; 78():78. PubMed ID: 32944237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human biomonitoring guidance values (HBM-GVs) for priority substances under the HBM4EU initiative - New values derivation for deltamethrin and cyfluthrin and overall results.
    Apel P; Lamkarkach F; Lange R; Sissoko F; David M; Rousselle C; Schoeters G; Kolossa-Gehring M
    Int J Hyg Environ Health; 2023 Mar; 248():114097. PubMed ID: 36577283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. From science to policy: How European HBM indicators help to answer policy questions related to phthalates and DINCH exposure.
    Gerofke A; David M; Schmidt P; Vicente JL; Buekers J; Gilles L; Colles A; Bessems J; Bastiaensen M; Covaci A; Den Hond E; Koppen G; Laeremans M; Verheyen VJ; Černá M; Klánová J; Krsková A; Zvonař M; Knudsen LE; Koch HM; Jensen TK; Rambaud L; Riou M; Vogel N; Gabriel C; Karakitsios S; Papaioannou N; Sarigiannis D; Kakucs R; Középesy S; Rudnai P; Szigeti T; Barbone F; Rosolen V; Guignard C; Gutleb AC; Sakhi AK; Haug LS; Janasik B; Ligocka D; Estokova M; Fabelova L; Kolena B; Murinova LP; Petrovicova I; Richterova D; Horvat M; Mazej D; Tratnik JS; Runkel AA; Castaño A; Esteban-López M; Pedraza-Díaz S; Åkesson A; Lignell S; Vlaanderen J; Zock JP; Schoeters G; Kolossa-Gehring M
    Int J Hyg Environ Health; 2023 Jan; 247():114073. PubMed ID: 36434900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current EU research activities on combined exposure to multiple chemicals.
    Bopp SK; Barouki R; Brack W; Dalla Costa S; Dorne JCM; Drakvik PE; Faust M; Karjalainen TK; Kephalopoulos S; van Klaveren J; Kolossa-Gehring M; Kortenkamp A; Lebret E; Lettieri T; Nørager S; Rüegg J; Tarazona JV; Trier X; van de Water B; van Gils J; Bergman Å
    Environ Int; 2018 Nov; 120():544-562. PubMed ID: 30170309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human risk associated with exposure to mixtures of antiandrogenic chemicals evaluated using in vitro hazard and human biomonitoring data.
    Ma Y; Taxvig C; Rodríguez-Carrillo A; Mustieles V; Reiber L; Kiesow A; Löbl NM; Fernández MF; Hansen TVA; Valente MJ; Kolossa-Gehring M; David M; Vinggaard AM
    Environ Int; 2023 Mar; 173():107815. PubMed ID: 36822008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Should the scope of human mixture risk assessment span legislative/regulatory silos for chemicals?
    Evans RM; Martin OV; Faust M; Kortenkamp A
    Sci Total Environ; 2016 Feb; 543(Pt A):757-764. PubMed ID: 26573369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The European Human Biomonitoring Initiative (HBM4EU): Human biomonitoring guidance values (HBM-GVs) for the aprotic solvents N-methyl-2-pyrrolidone (NMP) and N-ethyl-2-pyrrolidone (NEP).
    David M; Gerofke A; Lange R; Kolossa-Gehring M; Apel P
    Int J Hyg Environ Health; 2021 Sep; 238():113856. PubMed ID: 34619432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Approaches to mixture risk assessment of PFASs in the European population based on human hazard and biomonitoring data.
    Bil W; Govarts E; Zeilmaker MJ; Woutersen M; Bessems J; Ma Y; Thomsen C; Haug LS; Lignell S; Gyllenhammar I; Palkovicova Murinova L; Fabelova L; Tratnik JS; Kosjek T; Gabriel C; Sarigiannis D; Pedraza-Diaz S; Esteban-López M; Castaño A; Rambaud L; Riou M; Franken C; Colles A; Vogel N; Kolossa-Gehring M; Halldorsson TI; Uhl M; Schoeters G; Santonen T; Vinggaard AM
    Int J Hyg Environ Health; 2023 Jan; 247():114071. PubMed ID: 36446273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HBM4EU from the Coordinator's perspective: lessons learnt from managing a large-scale EU project.
    Kolossa-Gehring M; Pack LK; Hülck K; Gehring T
    Int J Hyg Environ Health; 2023 Jan; 247():114072. PubMed ID: 36395655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current Advances, Research Needs and Gaps in Mycotoxins Biomonitoring under the HBM4EU-Lessons Learned and Future Trends.
    Alvito P; Assunção RM; Bajard L; Martins C; Mengelers MJB; Mol H; Namorado S; van den Brand AD; Vasco E; Viegas S; Silva MJ
    Toxins (Basel); 2022 Nov; 14(12):. PubMed ID: 36548723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of Real-Life Mixtures Using Human Biomonitoring Data: A Proof of Concept Study.
    Rodriguez Martin L; Ottenbros I; Vogel N; Kolossa-Gehring M; Schmidt P; Řiháčková K; Juliá Molina M; Varea-Jiménez E; Govarts E; Pedraza-Diaz S; Lebret E; Vlaanderen J; Luijten M
    Toxics; 2023 Feb; 11(3):. PubMed ID: 36976969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Occupational Exposure to Hexavalent Chromium, Nickel and PAHs: A Mixtures Risk Assessment Approach Based on Literature Exposure Data from European Countries.
    Tavares AM; Viegas S; Louro H; Göen T; Santonen T; Luijten M; Kortenkamp A; Silva MJ
    Toxics; 2022 Jul; 10(8):. PubMed ID: 36006111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physiologically based kinetic (PBK) modelling and human biomonitoring data for mixture risk assessment.
    Pletz J; Blakeman S; Paini A; Parissis N; Worth A; Andersson AM; Frederiksen H; Sakhi AK; Thomsen C; Bopp SK
    Environ Int; 2020 Oct; 143():105978. PubMed ID: 32763630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HBM4EU combines and harmonises human biomonitoring data across the EU, building on existing capacity - The HBM4EU survey.
    Gilles L; Govarts E; Rambaud L; Vogel N; Castaño A; Esteban López M; Rodriguez Martin L; Koppen G; Remy S; Vrijheid M; Montazeri P; Birks L; Sepai O; Stewart L; Fiddicke U; Loots I; Knudsen LE; Kolossa-Gehring M; Schoeters G
    Int J Hyg Environ Health; 2021 Aug; 237():113809. PubMed ID: 34455198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suspect and non-targeted screening of chemicals of emerging concern for human biomonitoring, environmental health studies and support to risk assessment: From promises to challenges and harmonisation issues.
    Pourchet M; Debrauwer L; Klanova J; Price EJ; Covaci A; Caballero-Casero N; Oberacher H; Lamoree M; Damont A; Fenaille F; Vlaanderen J; Meijer J; Krauss M; Sarigiannis D; Barouki R; Le Bizec B; Antignac JP
    Environ Int; 2020 Jun; 139():105545. PubMed ID: 32361063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Considering the cumulative risk of mixtures of chemicals - a challenge for policy makers.
    Sarigiannis DA; Hansen U
    Environ Health; 2012 Jun; 11 Suppl 1(Suppl 1):S18. PubMed ID: 22759500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.